Photo via BBC News

Massive hope for pancreatic cancer pill after trial saw tumours vanish

Read the original at BBC News ↗
Cite

Roberts, M. (2026, November 20). Massive hope for pancreatic cancer pill after trial saw tumours vanish. BBC News. https://www.bbc.co.uk/news/articles/cqrmgjnzz9l0o?at_medium=RSS&at_campaign=rss

Dated from the outlet's own feed. Check the original for its byline.

BBC News · collected 2026-11-20 · by Michelle Roberts

Quick Summary

Experts are heralding a daily pill called daraxonrasib as a major breakthrough in pancreatic cancer treatment, with some patients showing undetectable tumors on scans. In a trial involving 61 recently diagnosed patients with advanced pancreatic cancer, tumors stopped growing in 90% of participants, and for around 8%, or one in 12, tumors became undetectable. While this is considered highly promising, doctors emphasize the need for longer-term studies to understand the drug's full impact and duration of effectiveness. Cancer Research UK calls it "the biggest leap forward in decades" for pancreatic cancer, highlighting the drug's potential to target previously "undruggable" mutations.
Written by AI on 2026-11-20, from this article's own text only (the story summary below draws on all the coverage).
See how they differ ↓

AI analysis

Story summary

A new drug called daraxonrasib, when combined with chemotherapy, has shown significant promise in treating advanced pancreatic cancer. In early clinical trials presented at the EORTC-NCI-AACR Symposium in Barcelona, tumors either shrank or stopped growing in almost all of the 61 patients who had recently been diagnosed with the disease that had spread to other parts of the body. Specifically, the cancer became undetectable in one in 12 patients. Although doctors emphasize that the pill is not yet a cure and its long-term effectiveness is still unknown, they consider it a major breakthrough, as pancreatic cancer has the lowest survival rate of all common cancers in the UK, with only about 3% of patients surviving five years after diagnosis. Cancer Research UK hailed the results as "the biggest leap forward in decades." Longer studies will be needed to determine the drug's full potential.

Written for “Pancreatic Cancer Pill Breakthrough” on 2026-11-21, grounded in this article and the 3 other(s) covering the same event.

How they differ

4 outlets covered “Pancreatic Cancer Pill Breakthrough”.

What each outlet says

One AI summary per outlet of its latest article on this story, written from that article alone and checked against it. Open the article for the outlet's own words.

BBCThis outlet20 Nov

Experts are heralding a daily pill called daraxonrasib as a major breakthrough in pancreatic cancer treatment, with some patients showing undetectable tumors on scans. In a trial involving 61 recently diagnosed patients with advanced pancreatic cancer, tumors stopped growing in 90% of participants, and for around 8%, or one in 12, tumors became undetectable. While this is considered highly promising, doctors…

Massive hope for pancreatic cancer pill after trial saw tumours vanish (this article)
The Guardian20 Nov

Doctors are celebrating early results from a trial of a new pill called daraxonrasib for pancreatic cancer, which showed that in one in 12 patients, the cancer became undetectable. In the trial involving 61 patients with advanced cancer that had spread, tumours stopped growing in 90% of cases, and over 60% saw their tumours shrink or disappear. Dr. Wungki Park, who presented the findings at a symposium in Barcelona…

Pill to treat pancreatic cancer hailed as ‘biggest breakthrough in decades’ →
New York Post20 Nov

A new treatment for pancreatic cancer, involving the drug daraxonrasib combined with chemotherapy, has shown unprecedented results in clinical trials. In these trials, the combination therapy caused tumors to stop growing or shrink significantly, with some tumors becoming undetectable. Specifically, 8.2% of patients had no trace of cancer by the end of the study, and more than 76% of participants survived for at…

‘Massive breakthrough’ as new pancreatic cancer treatment can make tumors disappear: ‘We’ve never seen such a thing’ →
Fox News21 Nov

A new drug combination involving an experimental pill called daraxonrasib and standard chemotherapy has shown promising results in treating advanced pancreatic cancer. In a phase 1/2 trial presented at the EORTC-NCI-AACR Symposium in Barcelona, this combination shrank tumors or halted their growth in 90.2% of 61 patients, with 60.7% experiencing tumor shrinkage, including 8.2% who saw complete response. The median…

New drug combo shrinks tumors in most patients facing aggressive cancer type →

Compared with similar articles

This article reads unscored and hedges 29% of its claims. Each row says how that neighbour differs.
The Guardian
Hedges 3 of 19 claims Outlet record 64/100
Fox News
Hedges 2 of 22 claims Outlet record 66/100

Story

Pancreatic Cancer Pill Breakthrough
Health · 4 article(s) covering the same event. See how they differ ↑
How this article was measured signals, leaning charts, publisher record, byline, topics and claims

Signals How these are calculated →

Claims extracted
21
sentences that state something as happening or true
Uncertain
29%
6 of 21 hedged ("reportedly", "may", "according to")
Leaning
not political
takes no side on a contested political question
Publisher signals
65/100
BBC News's corrections and hedging, across everything collected from it. Not a measure of accuracy.
Outlets on this story
4
Health
Same framing elsewhere
1
articles that frame the event the way this one does
Analyzed 2026-11-20 · how these are computed

How this is being covered How these are calculated →

Article leaning vs. publisher reliability
Source leaning vs. consistency

Publisher

BBC News · 6387 article(s) · 9 correction(s) detected
Running correction rate · 9 correction(s)

Who wrote this

Michelle Roberts
13 article(s) here · 1 carrying a prediction
But doctors stress it is a long way from knowing how long it might keep the disease at bay and should not be seen as a cure.
- Published Women arrested or convicted for having illegal abortions will have their criminal records wiped as new automatic pardons come into force in England and Wales, external.
2026-11-16 · assertive framing · Women's criminal records wiped for abortion offences
They tests are already available in some places but could now be offered across England.
Concerns from staff, parents, carers or the child themselves will trigger an immediate escalation of care.
- Published Eating fruit and vegetable scraps such as peels and stalks could provide a health boost that most of us are missing, say UK researchers, external.
- Published Only properly trained professionals will be allowed to offer high-risk cosmetic procedures like liquid Brazilian butt lifts (BBLs), vampire facials and chemical peels, under long-awaited government plans for England in 2027.
David Mais, from the ONS, said vapers were getting older and that "may reflect existing users getting older, growing popularity among this age group, or a combination of both". Smoke-free generation New legislation in the UK, external, taking affect in the new year, will permanently ban the legal sale of tobacco to anyone born on or after January 1, 2009 to create a "smoke-free" generation. Hazel Cheeseman, from the charity Action on Smoking and Health, said the latest statics showed encouraging progress in cutting smoking rates.
Medics at Alder Hey Hospital in Liverpool say some patients - they have had over 100 referrals since opening last May - describe 'peeing a jellyfish', which is some of the bladder's protective lining being shed.
Rare, but it could happen again "
Another goal - a 65% reduction in hepatitis C-related mortality compared with 2015 levels - has yet to be met, but might be before the 2030 target date.
2026-08-11 · assertive framing · England set to eliminate hepatitis C
Also by Michelle Roberts
Nothing else under this byline is closely related to this article, so these are simply their most recent.
All 13 articles by Michelle Roberts →

Topics

BBC News Cancer Research UK Daraxonrasib European Memorial Sloan Kettering Cancer Center

Subjects

Cancer Research UK ORG · 2× BBC News ORG · 1× Britain GPE · 1× EORTC ORG · 1× Elena Garralda PERSON · 1× European NORP · 1× Godfrey PERSON · 1× Memorial Sloan Kettering Cancer Center ORG · 1× Sam Godfrey PERSON · 1× Wungki Park PERSON · 1×

Narrative

"We are finally seeing progress in pancreatic cancer which is so long overdue." Pancreatic cancer is notoriously hard to treat and has the lowest survival rate of all common cancers in the UK. Although chemotherapy can shrink tumours a bit, the cancer often grows again.
framing: mixed · carried by 1 article(s) · first seen 2026-11-20
But doctors stress it is a long way from knowing how long it might keep the disease at bay and should not be seen as a cure.

Claims (21 extracted, 6 hedged)

- Published Experts are calling it the biggest breakthrough in pancreatic cancer treatment for decades - a daily pill that appears to shrink and possibly even eliminate tumours in some patients with one of the deadliest and hardest-to-treat cancers. uncertain
that → publish → cancers
Cancer became undetectable on scans in one in 12 of the patients given daraxonrasib along with chemotherapy in early medical trials. asserted
Cancer → become → trials
Tumours stopped growing in almost all of the 61 participants who had recently been diagnosed with advanced pancreatic cancer that had spread to other parts of the body. asserted
that → stop → body
But doctors stress it is a long way from knowing how long it might keep the disease at bay and should not be seen as a cure. uncertain
it → stress → cure
Incredibly exciting Cancer Research UK called it "the biggest leap forward in decades" for pancreatic cancer patients. asserted
UK → call → patients
The charity's Dr Sam Godfrey told BBC News that the results were incredibly exciting. asserted
results → tell → News
"What this new drug has done is it's found a way of drugging the undruggable. asserted
it → do → undruggable
"We are finally seeing progress in pancreatic cancer which is so long overdue." Pancreatic cancer is notoriously hard to treat and has the lowest survival rate of all common cancers in the UK. Although chemotherapy can shrink tumours a bit, the cancer often grows again. asserted
cancer → see → tumours
Most patients with advanced disease survive months, not years. asserted
patients → survive → months
Doctors hope the new treatment might offer patients more time, even if it cannot stop cancers for good. uncertain
it → hope → cancers
The trial followed patients for a year and a half, on average, and some did not see their cancer return during this time. asserted
cancer → follow → time
Longer studies are needed to understand if any of these cancers can be put into remission and for how long. asserted
any → need → remission
In the trial: tumours stopped growing in 90% of patients just over 60% of patients saw their tumours shrink or disappear for around 8% of patients, or one in 12, tumours became undetectable on CT scans asserted
tumours → stop → scans
Dr Wungki Park, from Memorial Sloan Kettering Cancer Center in the US and who is involved in the trial, said the results were extremely encouraging so far. "We are beginning to see not only a higher percentage of tumour response rates, but also deeper responses and a near doubling in the duration of disease control, which may eventually translate into longer survival," he said. uncertain
he → involve → survival
Daraxonrasib is a KRAS inhibitor treatment that has already been approved in the US. asserted
that → approve → US
It works by locking on to and shutting off certain mutations, called RAS, external, found in most pancreatic cancers that drive tumour growth. asserted
that → work → growth
Dozens of other cancers, including lung and ovarian, can have similar mutations, meaning the drug might help lots of other patients too. uncertain
drug → include → patients
Dr Godfrey said: "I would hope that the early success that we are beginning to see in pancreatic cancer can also be rolled out to other cancers." asserted
we → say → cancers
He said longer trials and results were vital. asserted
trials → say → ?
"Cancer can come back and even if scans show there is no sign of it, you don't necessarily know you are cancer-free until more time has passed." asserted
time → come → it
Prof Elena Garralda, chair of a European cancer conference called EORTC where the work is being presented to other doctors, said: "These results are exciting because they show the combined treatment could potentially significantly improve patients' overall survival, as well as the time before tumours start to grow again." There are 11,500 diagnoses of the disease in Britain each year and around 10,200 deaths, according to Cancer Research UK. Actor Alan Rickman died of the disease in 2016, five months after diagnosis. Symptoms can include, external jaundice, itchy skin, darker pee, paler poo, unexplained weight loss, tiredness and high temperature. uncertain
Symptoms → call → jaundice
Give feedback · no sign-in needed

No sign-in needed for now. Your note is sent without a name, so it cannot be answered.

History Support